Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Nov;24(5):663–666. doi: 10.1128/aac.24.5.663

Efficacy and safety of ceftriaxone in serious pediatric infections.

S C Aronoff, D Murdell, C A O'Brien, J D Klinger, M D Reed, J L Blumer
PMCID: PMC185918  PMID: 6318653

Abstract

Thirty-four patients aged 1 month to 19 years were treated with ceftriaxone for suspected bacterial infections. Bacterial pathogens were isolated from 25 children. The overall bacterial cure rate was 88%, with an overall clinical response rate of 96%. No side effects requiring cessation of therapy were observed. Ceftriaxone proved to be safe and effective in the treatment of serious infections in children.

Full text

PDF
664

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Eickhoff T. C., Ehret J. Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative. Antimicrob Agents Chemother. 1981 Mar;19(3):435–442. doi: 10.1128/aac.19.3.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Epstein J. S., Hasselquist S. M., Simon G. L. Efficacy of ceftriaxone in serious bacterial infections. Antimicrob Agents Chemother. 1982 Mar;21(3):402–406. doi: 10.1128/aac.21.3.402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fernex M., Havas L. Reports on cephtriaxone (Rocephin). Introduction and review. Chemotherapy. 1981;27 (Suppl 1):1–8. doi: 10.1159/000238020. [DOI] [PubMed] [Google Scholar]
  4. McNamara B. T., Meyer R. D., Pasiecznik K. A. In vitro susceptibility of cephalothin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to Amikacin and selected new beta-lactam agents. Antimicrob Agents Chemother. 1982 May;21(5):753–757. doi: 10.1128/aac.21.5.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Muytjens H. L., van der Ros-van de Repe J. Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother. 1982 Jun;21(6):925–934. doi: 10.1128/aac.21.6.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Patel I. H., Miller K., Weinfeld R., Spicehandler J. Multiple intravenous dose pharmacokinetics of ceftriaxone in man. Chemotherapy. 1981;27 (Suppl 1):47–56. doi: 10.1159/000238029. [DOI] [PubMed] [Google Scholar]
  7. Patel I. H., Weinfeld R. E., Konikoff J., Parsonnet M. Pharmacokinetics and tolerance of ceftriaxone in humans after single-dose intramuscular administration in water and lidocaine diluents. Antimicrob Agents Chemother. 1982 Jun;21(6):957–962. doi: 10.1128/aac.21.6.957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Schaad U. B., Stoeckel K. Single-dose pharmacokinetics of ceftriaxone in infants and young children. Antimicrob Agents Chemother. 1982 Feb;21(2):248–253. doi: 10.1128/aac.21.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES